SANGAMO THERAPEUTICS, INC Quarterly Debt-to-equity in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sangamo Therapeutics, Inc quarterly Debt-to-equity history and growth rate from Q3 2012 to Q2 2024.
  • Sangamo Therapeutics, Inc Debt-to-equity for the quarter ending June 30, 2024 was 104 %, a 62.3% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 104 +39.8 +62.3% Jun 30, 2024
Q1 2024 65.1 -10.9 -14.3% Mar 31, 2024
Q4 2023 46.2 -47 -50.4% Dec 31, 2023
Q3 2023 54.9 -38.6 -41.2% Sep 30, 2023
Q2 2023 63.8 -29 -31.3% Jun 30, 2023
Q1 2023 76 -15.1 -16.6% Mar 31, 2023
Q4 2022 93.2 +4.16 +4.67% Dec 31, 2022
Q3 2022 93.5 +5.28 +5.99% Sep 30, 2022
Q2 2022 92.9 +5.96 +6.86% Jun 30, 2022
Q1 2022 91.1 +7.42 +8.87% Mar 31, 2022
Q4 2021 89 +13.3 +17.6% Dec 31, 2021
Q3 2021 88.2 +22.5 +34.3% Sep 30, 2021
Q2 2021 86.9 +30 +52.8% Jun 30, 2021
Q1 2021 83.7 +33.8 +67.8% Mar 31, 2021
Q4 2020 75.7 +22.4 +41.9% Dec 31, 2020
Q3 2020 65.7 +8.87 +15.6% Sep 30, 2020
Q2 2020 56.8 -1.78 -3.04% Jun 30, 2020
Q1 2020 49.9 -11.9 -19.2% Mar 31, 2020
Q4 2019 53.3 -6.54 -10.9% Dec 31, 2019
Q3 2019 56.8 -1.59 -2.72% Sep 30, 2019
Q2 2019 58.6 +3.52 +6.39% Jun 30, 2019
Q1 2019 61.8 +12.5 +25.4% Mar 31, 2019
Q4 2018 59.9 +17.8 +42.4% Dec 31, 2018
Q3 2018 58.4 +24.9 +74.5% Sep 30, 2018
Q2 2018 55.1 +29.6 +116% Jun 30, 2018
Q1 2018 49.2 +34.2 +228% Mar 31, 2018
Q4 2017 42.1 +28.9 +220% Dec 31, 2017
Q3 2017 33.5 +21 +168% Sep 30, 2017
Q2 2017 25.5 +13 +103% Jun 30, 2017
Q1 2017 15 +1.92 +14.7% Mar 31, 2017
Q4 2016 13.1 -1.15 -8.05% Dec 31, 2016
Q3 2016 12.5 -2.98 -19.3% Sep 30, 2016
Q2 2016 12.6 -3.81 -23.3% Jun 30, 2016
Q1 2016 13.1 -3.77 -22.4% Mar 31, 2016
Q4 2015 14.3 -3.2 -18.3% Dec 31, 2015
Q3 2015 15.5 -1.66 -9.69% Sep 30, 2015
Q2 2015 16.4 +0.48 +3.02% Jun 30, 2015
Q1 2015 16.9 +0.41 +2.49% Mar 31, 2015
Q4 2014 17.5 +0.55 +3.25% Dec 31, 2014
Q3 2014 17.1 -2.39 -12.2% Sep 30, 2014
Q2 2014 15.9 -8.75 -35.5% Jun 30, 2014
Q1 2014 16.4 -7.65 -31.8% Mar 31, 2014
Q4 2013 16.9 -6.71 -28.4% Dec 31, 2013
Q3 2013 19.5 +0.71 +3.77% Sep 30, 2013
Q2 2013 24.6 Jun 30, 2013
Q1 2013 24.1 Mar 31, 2013
Q4 2012 23.6 Dec 31, 2012
Q3 2012 18.8 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.